WEST PHARMACEUTICAL SERVICES, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements of $1.40 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-22.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements · last filed 2022-02-22
- WEST PHARMACEUTICAL SERVICES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2021-12-31 was $400.00K, a 100.00% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2021-09-30 was $200.00K, a 50.00% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2021-06-30 was $400.00K, a 100.00% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2021-03-31 was $400.00K, a 300.00% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2021 was $1.40M, a 55.56% increase from fiscal 2020.
- WEST PHARMACEUTICAL SERVICES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2020 was $900.00K, a 80.00% increase from fiscal 2019.
- WEST PHARMACEUTICAL SERVICES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2019 was $500.00K, a 16.67% decline from fiscal 2018.
- WEST PHARMACEUTICAL SERVICES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2018 was $600.00K, a 14.29% decline from fiscal 2017.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 12 month |
|---|---|---|---|---|
| 2021-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $600.00K derived: sum of 2 quarters · filed 2022-02-22 | $1.00M derived: sum of 3 quarters · filed 2022-02-22 | $1.40M 10-K · filed 2022-02-22 |
| 2021-09-30 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $600.00K derived: sum of 2 quarters · filed 2021-10-28 | $1.00M 10-Q · filed 2021-10-28 | $1.20M derived: sum of 4 quarters · filed 2022-02-22 |
| 2021-06-30 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $800.00K 10-Q · filed 2021-07-30 | $1.00M derived: sum of 3 quarters · filed 2022-02-22 | $1.40M derived: sum of 4 quarters · filed 2022-02-22 |
| 2021-03-31 | $400.00K 10-Q · filed 2021-04-30 | $600.00K derived: sum of 2 quarters · filed 2022-02-22 | $1.00M derived: sum of 3 quarters · filed 2022-02-22 | $1.20M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $600.00K derived: sum of 2 quarters · filed 2022-02-22 | $800.00K derived: sum of 3 quarters · filed 2022-02-22 | $900.00K 10-K · filed 2022-02-22 |
| 2020-09-30 | $400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-23 | $600.00K derived: sum of 2 quarters · filed 2020-10-23 | $700.00K 10-Q · filed 2020-10-23 | $900.00K derived: sum of 4 quarters · filed 2021-02-23 |
| 2020-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-24 | $300.00K 10-Q · filed 2020-07-24 | $500.00K derived: sum of 3 quarters · filed 2021-02-23 | $500.00K derived: sum of 4 quarters · filed 2021-02-23 |
| 2020-03-31 | $100.00K 10-Q · filed 2020-04-24 | $300.00K derived: sum of 2 quarters · filed 2021-02-23 | $300.00K derived: sum of 3 quarters · filed 2021-02-23 | $400.00K derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $200.00K derived: sum of 2 quarters · filed 2021-02-23 | $300.00K derived: sum of 3 quarters · filed 2021-02-23 | $500.00K 10-K · filed 2021-02-23 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | $100.00K derived: sum of 2 quarters · filed 2019-10-29 | $300.00K 10-Q · filed 2019-10-29 | $400.00K derived: sum of 4 quarters · filed 2020-02-24 |
| 2019-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-29 | $300.00K 10-Q · filed 2019-07-29 | $400.00K derived: sum of 3 quarters · filed 2020-02-24 | $400.00K derived: sum of 4 quarters · filed 2020-02-24 |
| 2019-03-31 | $200.00K 10-Q · filed 2019-05-08 | $300.00K derived: sum of 2 quarters · filed 2020-02-24 | $300.00K derived: sum of 3 quarters · filed 2020-02-24 | $600.00K derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $100.00K derived: sum of 2 quarters · filed 2020-02-24 | $400.00K derived: sum of 3 quarters · filed 2020-02-24 | $600.00K 10-K · filed 2020-02-24 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $300.00K derived: sum of 2 quarters · filed 2018-10-30 | $500.00K 10-Q · filed 2018-10-30 | $700.00K derived: sum of 4 quarters · filed 2019-02-28 |
| 2018-06-30 | $300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | $500.00K 10-Q · filed 2018-07-31 | $700.00K derived: sum of 3 quarters · filed 2019-02-28 | $1.00M derived: sum of 4 quarters · filed 2019-02-28 |
| 2018-03-31 | $200.00K 10-Q · filed 2018-05-08 | $400.00K derived: sum of 2 quarters · filed 2019-02-28 | $700.00K derived: sum of 3 quarters · filed 2019-02-28 | $800.00K derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $500.00K derived: sum of 2 quarters · filed 2019-02-28 | $600.00K derived: sum of 3 quarters · filed 2019-02-28 | $700.00K 10-K · filed 2019-02-28 |
| 2017-09-30 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $400.00K derived: sum of 2 quarters · filed 2017-10-31 | $500.00K 10-Q · filed 2017-10-31 | $700.00K derived: sum of 4 quarters · filed 2018-02-26 |
| 2017-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $200.00K 10-Q · filed 2017-08-01 | $400.00K derived: sum of 3 quarters · filed 2018-02-26 | $500.00K derived: sum of 4 quarters · filed 2018-02-26 |
| 2017-03-31 | $100.00K 10-Q · filed 2017-05-05 | $300.00K derived: sum of 2 quarters · filed 2018-02-26 | $400.00K derived: sum of 3 quarters · filed 2018-02-26 | $400.00K derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $300.00K derived: sum of 2 quarters · filed 2018-02-26 | $300.00K derived: sum of 3 quarters · filed 2018-02-26 | $300.00K 10-K · filed 2018-02-26 |
| 2016-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-31 | $100.00K derived: sum of 2 quarters · filed 2016-10-31 | $100.00K 10-Q · filed 2016-10-31 | $100.00K derived: sum of 4 quarters · filed 2017-05-05 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | $0.00 10-Q · filed 2016-08-01 | $0.00 derived: sum of 3 quarters · filed 2017-05-05 | $0.00 derived: sum of 4 quarters · filed 2017-05-05 |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-05 | $0.00 derived: sum of 2 quarters · filed 2017-05-05 | $0.00 derived: sum of 3 quarters · filed 2017-05-05 | $0.00 derived: sum of 4 quarters · filed 2017-05-05 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $0.00 derived: sum of 2 quarters · filed 2017-02-28 | $0.00 derived: sum of 3 quarters · filed 2017-02-28 | $100.00K 10-K · filed 2017-02-28 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-31 | $0.00 derived: sum of 2 quarters · filed 2016-10-31 | $100.00K 10-Q · filed 2016-10-31 | $200.00K derived: sum of 4 quarters · filed 2016-10-31 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | $100.00K 10-Q · filed 2016-08-01 | $200.00K derived: sum of 3 quarters · filed 2016-08-01 | $300.00K derived: sum of 4 quarters · filed 2016-08-01 |
| 2015-03-31 | $100.00K 10-Q · filed 2016-05-06 | $200.00K derived: sum of 2 quarters · filed 2016-05-06 | $300.00K derived: sum of 3 quarters · filed 2016-05-06 | |
| 2014-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $200.00K derived: sum of 2 quarters · filed 2016-02-26 | $300.00K 10-K · filed 2016-02-26 | |
| 2014-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $200.00K 10-Q · filed 2015-11-02 | ||
| 2014-06-30 | $100.00K 10-Q · filed 2015-08-03 | |||
| 2013-12-31 | $100.00K 10-K · filed 2015-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |